AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -70.0% | 57,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $10,000 | -63.0% | 57,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $27,000 | -15.6% | 57,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -59.0% | 57,000 | +21.3% | 0.00% | -66.7% |
| Q3 2021 | $78,000 | +25.8% | 47,000 | +27.0% | 0.01% | +50.0% |
| Q2 2021 | $62,000 | +51.2% | 37,000 | +54.2% | 0.00% | +33.3% |
| Q1 2021 | $41,000 | +7.9% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | +52.0% | 24,000 | -7.7% | 0.00% | +50.0% |
| Q3 2020 | $25,000 | +56.2% | 26,000 | +4.0% | 0.00% | 0.0% |
| Q2 2020 | $16,000 | +60.0% | 25,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $10,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |